Cencora, Inc. · NYSE:COR
Cencora — AmerisourceBergen — J.P. Morgan Healthcare Conference 2014
18 slides from Cencora's conference presentation, Jan 14, 2014
Slide 1: J.P. Morgan Healthcare Conference
J.P. Morgan Healthcare Conference January 14, 2014
Slide 2: Cautionary Note Regarding Forward-Looking Statements
Cautionary Note Regarding Forward-Looking Statements Certain of the statements contained in this presentation are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Words such as "expect," "likely," "ou
Slide 3: President and Chief Executive Officer
President and Chief Executive Officer
Slide 4: Improving US Market
Delivering Growth Improving US Market Pharmaceutical Sales Trends in 2014 $ millions 380 12.0% and Beyond 370 10.0% + demographics 360 8.0% + expansion of coverage 350 + new brand drug launches 340 6.0% + better generic launches 330 + strong pricing environment 4.0% 320 – increased focus on value 2.
Slide 5: Even Greater Opportunities Globally
Delivering Growth Even Greater Opportunities Globally Global Spending Global Spending on Medicines on Specialty 2017 2017 $1.2 Trillion $235 Billion +24% +38% 2012 2012 $965 Billion $171 Billion 5
Slide 6: Well Positioned to Seize Global Opportunities
Delivering Growth Well Positioned to Seize Global Opportunities Global Sourcing and Distribution Services Pharmacy Provider Manufacturer Solutions Solutions Solutions > Drive greater > Drive practice > Maximize product operational efficiency, efficiency, financial success at every cost control, grow
Slide 7: Strategic Relationship with Walgreens and Alliance Boots
Strategic Relationship with Walgreens and Alliance Boots Best Partners and Greatest Reach > 10 Year Distribution Contract With Walgreens > Global Sourcing Contribution > Platform Leverage, Domestic & International > Interests Aligned Through Equity Position STRENGTHENS NEARLY EVERY ASPECT OF OUR BUS
Slide 8: Walgreens Contract Implementation
Delivering Growth Walgreens Contract Implementation Brand Volume Generic Volume Pilot August – December 2013 > Transition over January - TBD 2014 > Gradual transition > Enhance network May-August Labor Day automation & scale 2013 > Serve all stores > Last stage of hiring > System testing on Day
Slide 9: How Will We Continue to Drive Performance?
Delivering Growth How Will We Continue to Drive Performance? Knowledge, Reach and Partnership > Unsurpassed expertise in pharmaceutical distribution, commercialization, and consulting > Global reach in sourcing, distribution, and manufacturer services > Innovative collaboration with manufacturers an
Slide 10: Priorities for Fiscal 2014
Delivering Growth Priorities for Fiscal 2014 Strengthen and Expand Our Core Business Expand Specialty and Walgreens & > Drive solutions through cross Service Offerings in Alliance Boots company collaboration US & Internationally Strategic Relationship > Enhance independent retail > Leverage World Co
Slide 11: Senior Vice President and Chief Financial Officer
Senior Vice President and Chief Financial Officer
Slide 12: Revenues
Delivering Growth Revenues $88.0 $78.7 $78.1 $76.5 Billions $70.5 $68.6 2008 2009 2010 2011 2012 2013 12
Slide 13: Adjusted EBIT
Delivering Growth Adjusted EBIT $1,352 $1,256 $1,290 $1,102 $905 Millions $831 2008 2009 2010 2011 2012 2013 13
Slide 14: Adjusted Diluted EPS
Delivering Growth Adjusted Diluted EPS $3.21 $3.08 $2.67 $2.21 $1.74 $1.48 2008 2009 2010 2011 2012 2013 14
Slide 15: Cash Generation
Delivering Growth Cash Generation $1.4 $1.2 $1.0 Working $0.8 Billions Capital Impact $0.6 $0.4 $0.2 $0.0 2008 2009 2010 2011 2012 2013 Adjusted Net Income Free Cash Flow 15
Slide 16: Fiscal Year 2014 Targets
Delivering Growth Fiscal Year 2014 Targets Adjusted Diluted EPS in the range of $3.60 to $3.73, up 12% to 16% Revenue > Growth in 28% to 31% range > Dollar growth in the 12% to 16% range, Operating Income margin decline in the high teens > In the range of $500 to $700M including Free Cash Flow CapEx
Slide 17: Looking Ahead
Delivering Growth Looking Ahead > Better organic growth > Improving generic opportunities > Increasing operational efficiency > Significant EBIT expansion > Disciplined capital deployment 17
Slide 18: AmerisourceBergen
____AmerisourceBergen. Where knowledge, reach and partnership shape healthcare delivery. AmerisourceBergen: ere knowledge, reach and partnership shape healthcare delivery.
AmerisourceBergen — J.P. Morgan Healthcare Conference 2014 on 6ix